Current role
Biotechnology · Healthcare
Board Member
2024-03-28–present
Felix J. Baker, Ph.D.
Equibles does not estimate personal net worth.
Get an email with a short summary when Kymera Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get KYMR alertsAbout Felix J. Baker, Ph.D.
Felix J. Baker, Ph.D. is recorded as Board Member at Kymera Therapeutics, Inc. (KYMR) since March 28, 2024. Kymera Therapeutics, Inc. reported in an 8-K filed April 1, 2024 that Felix J. Baker, Ph.D. was appointed Lead Independent Director, effective March 28, 2024. Kymera Therapeutics, Inc. reported in an 8-K filed April 1, 2024 that Felix J. Baker, Ph.D. was appointed Class II director, effective March 28, 2024. Kymera Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Kymera Therapeutics, Inc. includes Bruce Jacobs (CFO), Jeremy Chadwick (COO), Jeremy Chadwick, Ph.D. (COO) and 7 others.
“Dr. Baker was also appointed to serve as the Lead Independent Director of the Board.”
“On March 28, 2024, upon the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the "Board") of Kymera Therapeutics, Inc. (the "Company"), the Board appointed Felix J. Baker, Ph.D. to join the Board, effective March 28, 2024.”
Affiliation history
-
Kymera Therapeutics, Inc. (KYMR)
SEC 8-K
Current2024-03-28–present
-
Current
2024-03-28–present
Company network
Leadership on record at Kymera Therapeutics, Inc.
- Bruce Jacobs CFO
- Jeremy Chadwick COO
- Jeremy Chadwick, Ph.D. COO
- Brian R. Adams General Counsel
- Brian R. Adams, J.D. General Counsel
- Bruce Booth Board Member
- Elena Ridloff Board Member
- Gorjan Hrustanovic, Ph.D. Board Member
- John Maraganore Board Member
- Nello Mainolfi Board Member